nodes	percent_of_prediction	percent_of_DWPC	metapath
Folic Acid—Methotrexate—lymphatic system cancer	0.434	1	CrCtD
Folic Acid—GGH—Methotrexate—lymphatic system cancer	0.078	0.294	CbGbCtD
Folic Acid—Pralatrexate—Methotrexate—lymphatic system cancer	0.0574	0.2	CrCrCtD
Folic Acid—Raltitrexed—Methotrexate—lymphatic system cancer	0.0574	0.2	CrCrCtD
Folic Acid—Pemetrexed—Methotrexate—lymphatic system cancer	0.0574	0.2	CrCrCtD
Folic Acid—Leucovorin—Methotrexate—lymphatic system cancer	0.0574	0.2	CrCrCtD
Folic Acid—Tetrahydrofolic acid—Methotrexate—lymphatic system cancer	0.0574	0.2	CrCrCtD
Folic Acid—SLC46A1—Methotrexate—lymphatic system cancer	0.0448	0.169	CbGbCtD
Folic Acid—ABCC11—Methotrexate—lymphatic system cancer	0.0375	0.141	CbGbCtD
Folic Acid—MTHFR—Methotrexate—lymphatic system cancer	0.0234	0.0881	CbGbCtD
Folic Acid—ABCC3—Vincristine—lymphatic system cancer	0.0171	0.0643	CbGbCtD
Folic Acid—ABCG2—Teniposide—lymphatic system cancer	0.0146	0.0549	CbGbCtD
Folic Acid—ABCC3—Methotrexate—lymphatic system cancer	0.0103	0.0389	CbGbCtD
Folic Acid—ABCG2—Mitoxantrone—lymphatic system cancer	0.0102	0.0384	CbGbCtD
Folic Acid—ABCC4—Methotrexate—lymphatic system cancer	0.0079	0.0297	CbGbCtD
Folic Acid—CYP2E1—Mitoxantrone—lymphatic system cancer	0.00727	0.0274	CbGbCtD
Folic Acid—ABCG2—Vincristine—lymphatic system cancer	0.00702	0.0264	CbGbCtD
Folic Acid—ABCG2—Methotrexate—lymphatic system cancer	0.00425	0.016	CbGbCtD
Folic Acid—SLC22A6—Methotrexate—lymphatic system cancer	0.00344	0.0129	CbGbCtD
Folic Acid—Digestion impaired—Fludarabine—lymphatic system cancer	0.000697	0.0521	CcSEcCtD
Folic Acid—Depression—Mechlorethamine—lymphatic system cancer	0.000401	0.03	CcSEcCtD
Folic Acid—Bronchospasm—Teniposide—lymphatic system cancer	0.000327	0.0244	CcSEcCtD
Folic Acid—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.000257	0.0192	CcSEcCtD
Folic Acid—Anorexia—Mechlorethamine—lymphatic system cancer	0.000245	0.0183	CcSEcCtD
Folic Acid—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.000223	0.0167	CcSEcCtD
Folic Acid—Agitation—Teniposide—lymphatic system cancer	0.000213	0.0159	CcSEcCtD
Folic Acid—Bronchospasm—Bleomycin—lymphatic system cancer	0.000211	0.0158	CcSEcCtD
Folic Acid—Confusional state—Teniposide—lymphatic system cancer	0.000191	0.0143	CcSEcCtD
Folic Acid—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000189	0.0141	CcSEcCtD
Folic Acid—Agitation—Fludarabine—lymphatic system cancer	0.000187	0.014	CcSEcCtD
Folic Acid—Malaise—Fludarabine—lymphatic system cancer	0.000184	0.0137	CcSEcCtD
Folic Acid—Pruritus—Mechlorethamine—lymphatic system cancer	0.000182	0.0136	CcSEcCtD
Folic Acid—Anorexia—Teniposide—lymphatic system cancer	0.00018	0.0135	CcSEcCtD
Folic Acid—Convulsion—Fludarabine—lymphatic system cancer	0.000176	0.0132	CcSEcCtD
Folic Acid—Discomfort—Fludarabine—lymphatic system cancer	0.000171	0.0128	CcSEcCtD
Folic Acid—Dyspnoea—Teniposide—lymphatic system cancer	0.000169	0.0126	CcSEcCtD
Folic Acid—Confusional state—Fludarabine—lymphatic system cancer	0.000168	0.0125	CcSEcCtD
Folic Acid—Depression—Carmustine—lymphatic system cancer	0.000166	0.0124	CcSEcCtD
Folic Acid—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.000166	0.0124	CcSEcCtD
Folic Acid—Decreased appetite—Teniposide—lymphatic system cancer	0.000164	0.0123	CcSEcCtD
Folic Acid—Rash—Mechlorethamine—lymphatic system cancer	0.000162	0.0121	CcSEcCtD
Folic Acid—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000162	0.0121	CcSEcCtD
Folic Acid—Depression—Vincristine—lymphatic system cancer	0.000159	0.0119	CcSEcCtD
Folic Acid—Anorexia—Fludarabine—lymphatic system cancer	0.000158	0.0118	CcSEcCtD
Folic Acid—Feeling abnormal—Teniposide—lymphatic system cancer	0.000156	0.0116	CcSEcCtD
Folic Acid—Nausea—Mechlorethamine—lymphatic system cancer	0.000152	0.0114	CcSEcCtD
Folic Acid—Erythema—Bleomycin—lymphatic system cancer	0.000149	0.0112	CcSEcCtD
Folic Acid—Dyspnoea—Fludarabine—lymphatic system cancer	0.000148	0.0111	CcSEcCtD
Folic Acid—Dyspepsia—Fludarabine—lymphatic system cancer	0.000146	0.0109	CcSEcCtD
Folic Acid—Decreased appetite—Fludarabine—lymphatic system cancer	0.000145	0.0108	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000144	0.0107	CcSEcCtD
Folic Acid—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000139	0.0104	CcSEcCtD
Folic Acid—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000137	0.0102	CcSEcCtD
Folic Acid—Malaise—Bleomycin—lymphatic system cancer	0.000135	0.0101	CcSEcCtD
Folic Acid—Pruritus—Teniposide—lymphatic system cancer	0.000134	0.01	CcSEcCtD
Folic Acid—Erythema—Carmustine—lymphatic system cancer	0.00013	0.00974	CcSEcCtD
Folic Acid—Discomfort—Bleomycin—lymphatic system cancer	0.000126	0.00939	CcSEcCtD
Folic Acid—Confusional state—Bleomycin—lymphatic system cancer	0.000123	0.00918	CcSEcCtD
Folic Acid—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000122	0.00911	CcSEcCtD
Folic Acid—Erythema—Mitoxantrone—lymphatic system cancer	0.000121	0.00906	CcSEcCtD
Folic Acid—Agitation—Carmustine—lymphatic system cancer	0.00012	0.00895	CcSEcCtD
Folic Acid—Rash—Teniposide—lymphatic system cancer	0.000119	0.00891	CcSEcCtD
Folic Acid—Dermatitis—Teniposide—lymphatic system cancer	0.000119	0.0089	CcSEcCtD
Folic Acid—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000119	0.00887	CcSEcCtD
Folic Acid—Pruritus—Fludarabine—lymphatic system cancer	0.000118	0.00879	CcSEcCtD
Folic Acid—Anorexia—Bleomycin—lymphatic system cancer	0.000116	0.00868	CcSEcCtD
Folic Acid—Agitation—Vincristine—lymphatic system cancer	0.000114	0.00855	CcSEcCtD
Folic Acid—Convulsion—Carmustine—lymphatic system cancer	0.000113	0.00844	CcSEcCtD
Folic Acid—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000112	0.0084	CcSEcCtD
Folic Acid—Nausea—Teniposide—lymphatic system cancer	0.000112	0.0084	CcSEcCtD
Folic Acid—Malaise—Mitoxantrone—lymphatic system cancer	0.000109	0.00817	CcSEcCtD
Folic Acid—Dyspnoea—Bleomycin—lymphatic system cancer	0.000109	0.00812	CcSEcCtD
Folic Acid—Convulsion—Vincristine—lymphatic system cancer	0.000108	0.00806	CcSEcCtD
Folic Acid—Confusional state—Carmustine—lymphatic system cancer	0.000107	0.00802	CcSEcCtD
Folic Acid—Decreased appetite—Bleomycin—lymphatic system cancer	0.000106	0.00792	CcSEcCtD
Folic Acid—Convulsion—Mitoxantrone—lymphatic system cancer	0.000105	0.00785	CcSEcCtD
Folic Acid—Rash—Fludarabine—lymphatic system cancer	0.000105	0.00783	CcSEcCtD
Folic Acid—Dermatitis—Fludarabine—lymphatic system cancer	0.000105	0.00782	CcSEcCtD
Folic Acid—Discomfort—Mitoxantrone—lymphatic system cancer	0.000102	0.00762	CcSEcCtD
Folic Acid—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000102	0.00759	CcSEcCtD
Folic Acid—Anorexia—Carmustine—lymphatic system cancer	0.000101	0.00758	CcSEcCtD
Folic Acid—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0001	0.00751	CcSEcCtD
Folic Acid—Confusional state—Mitoxantrone—lymphatic system cancer	9.97e-05	0.00745	CcSEcCtD
Folic Acid—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	9.89e-05	0.00739	CcSEcCtD
Folic Acid—Nausea—Fludarabine—lymphatic system cancer	9.87e-05	0.00738	CcSEcCtD
Folic Acid—Anorexia—Vincristine—lymphatic system cancer	9.68e-05	0.00723	CcSEcCtD
Folic Acid—Irritability—Methotrexate—lymphatic system cancer	9.57e-05	0.00715	CcSEcCtD
Folic Acid—Dyspnoea—Carmustine—lymphatic system cancer	9.49e-05	0.00709	CcSEcCtD
Folic Acid—Anorexia—Mitoxantrone—lymphatic system cancer	9.43e-05	0.00705	CcSEcCtD
Folic Acid—Decreased appetite—Carmustine—lymphatic system cancer	9.25e-05	0.00691	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Carmustine—lymphatic system cancer	9.19e-05	0.00686	CcSEcCtD
Folic Acid—Decreased appetite—Vincristine—lymphatic system cancer	8.83e-05	0.0066	CcSEcCtD
Folic Acid—Dyspnoea—Mitoxantrone—lymphatic system cancer	8.82e-05	0.00659	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Vincristine—lymphatic system cancer	8.77e-05	0.00655	CcSEcCtD
Folic Acid—Feeling abnormal—Carmustine—lymphatic system cancer	8.77e-05	0.00655	CcSEcCtD
Folic Acid—Dyspepsia—Mitoxantrone—lymphatic system cancer	8.71e-05	0.00651	CcSEcCtD
Folic Acid—Pruritus—Bleomycin—lymphatic system cancer	8.62e-05	0.00644	CcSEcCtD
Folic Acid—Decreased appetite—Mitoxantrone—lymphatic system cancer	8.6e-05	0.00642	CcSEcCtD
Folic Acid—Feeling abnormal—Mitoxantrone—lymphatic system cancer	8.15e-05	0.00609	CcSEcCtD
Folic Acid—Depression—Methotrexate—lymphatic system cancer	7.7e-05	0.00576	CcSEcCtD
Folic Acid—Rash—Bleomycin—lymphatic system cancer	7.69e-05	0.00574	CcSEcCtD
Folic Acid—Dermatitis—Bleomycin—lymphatic system cancer	7.68e-05	0.00574	CcSEcCtD
Folic Acid—Nausea—Bleomycin—lymphatic system cancer	7.24e-05	0.00541	CcSEcCtD
Folic Acid—Rash—Carmustine—lymphatic system cancer	6.71e-05	0.00501	CcSEcCtD
Folic Acid—Dermatitis—Carmustine—lymphatic system cancer	6.7e-05	0.00501	CcSEcCtD
Folic Acid—Rash—Vincristine—lymphatic system cancer	6.4e-05	0.00479	CcSEcCtD
Folic Acid—Dermatitis—Vincristine—lymphatic system cancer	6.4e-05	0.00478	CcSEcCtD
Folic Acid—Nausea—Carmustine—lymphatic system cancer	6.32e-05	0.00472	CcSEcCtD
Folic Acid—Rash—Mitoxantrone—lymphatic system cancer	6.24e-05	0.00466	CcSEcCtD
Folic Acid—Dermatitis—Mitoxantrone—lymphatic system cancer	6.23e-05	0.00466	CcSEcCtD
Folic Acid—Erythema—Methotrexate—lymphatic system cancer	6.04e-05	0.00451	CcSEcCtD
Folic Acid—Nausea—Vincristine—lymphatic system cancer	6.03e-05	0.00451	CcSEcCtD
Folic Acid—Dysgeusia—Methotrexate—lymphatic system cancer	5.91e-05	0.00442	CcSEcCtD
Folic Acid—Nausea—Mitoxantrone—lymphatic system cancer	5.88e-05	0.00439	CcSEcCtD
Folic Acid—Ill-defined disorder—Methotrexate—lymphatic system cancer	5.6e-05	0.00419	CcSEcCtD
Folic Acid—Malaise—Methotrexate—lymphatic system cancer	5.45e-05	0.00407	CcSEcCtD
Folic Acid—Convulsion—Methotrexate—lymphatic system cancer	5.23e-05	0.00391	CcSEcCtD
Folic Acid—Discomfort—Methotrexate—lymphatic system cancer	5.08e-05	0.0038	CcSEcCtD
Folic Acid—Confusional state—Methotrexate—lymphatic system cancer	4.97e-05	0.00371	CcSEcCtD
Folic Acid—Anaphylactic shock—Methotrexate—lymphatic system cancer	4.93e-05	0.00368	CcSEcCtD
Folic Acid—Anorexia—Methotrexate—lymphatic system cancer	4.7e-05	0.00351	CcSEcCtD
Folic Acid—Dyspnoea—Methotrexate—lymphatic system cancer	4.39e-05	0.00328	CcSEcCtD
Folic Acid—Dyspepsia—Methotrexate—lymphatic system cancer	4.34e-05	0.00324	CcSEcCtD
Folic Acid—Decreased appetite—Methotrexate—lymphatic system cancer	4.28e-05	0.0032	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	4.25e-05	0.00318	CcSEcCtD
Folic Acid—Feeling abnormal—Methotrexate—lymphatic system cancer	4.06e-05	0.00303	CcSEcCtD
Folic Acid—Pruritus—Methotrexate—lymphatic system cancer	3.49e-05	0.00261	CcSEcCtD
Folic Acid—Rash—Methotrexate—lymphatic system cancer	3.11e-05	0.00232	CcSEcCtD
Folic Acid—Dermatitis—Methotrexate—lymphatic system cancer	3.1e-05	0.00232	CcSEcCtD
Folic Acid—Nausea—Methotrexate—lymphatic system cancer	2.93e-05	0.00219	CcSEcCtD
